| . | Arm A: RT Alone (N = 12) . | Arm B: RT + Concomitant TMZ (N = 12) . | Arm C: TMZ Alone (N = 12) . |
|---|---|---|---|
| Group, n (%) | |||
| EORTC | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| North America | 6 (50.0) | 7 (58.3) | 6 (50.0) |
| Age, y | |||
| N | 12 | 12 | 12 |
| Mean (SD) | 48.3 (10.28) | 48.3 (9.19) | 42.5 (12.97) |
| Median | 50.0 | 48.5 | 43.5 |
| Range | 29.0, 66.0 | 31.0, 64.0 | 18.0, 61.0 |
| Sex, n (%) | |||
| Female | 3 (25.0) | 6 (50.0) | 2 (16.7) |
| Male | 9 (75.0) | 6 (50.0) | 10 (83.3) |
| ECOG Performance Score, n (%) | |||
| 0 | 9 (75.0) | 8 (66.7) | 9 (75.0) |
| 1 | 3 (25.0) | 4 (33.3) | 3 (25.0) |
| Previous Cancer, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 0 (0.0) |
| No | 11 (91.7) | 12 (100.0) | 12 (100.0) |
| Site Primary Tumor, n (%) | |||
| Right | 6 (50.0) | 8 (66.7) | 9 (75.0) |
| Left | 5 (41.7) | 3 (25.0) | 3 (25.0) |
| Bilateral | 1 (8.3) | 1 (8.3) | 0 (0.0) |
| Corticosteroid Therapy at Entry, n (%) | |||
| Yes | 3 (25.0) | 1 (8.3) | 4 (33.3) |
| No | 9 (75.0) | 11 (91.7) | 8 (66.7) |
| Extent Surgical Resection, n (%) | |||
| Biopsy | 0 (0.0) | 1 (8.3) | 2 (16.7) |
| Subtotal resection | 6 (50.0) | 6 (50.0) | 4 (33.3) |
| Gross total resection | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| Prior History Brain Tumor, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 1 (8.3) |
| No | 11 (91.7) | 12 (100.0) | 11 (91.7) |
| . | Arm A: RT Alone (N = 12) . | Arm B: RT + Concomitant TMZ (N = 12) . | Arm C: TMZ Alone (N = 12) . |
|---|---|---|---|
| Group, n (%) | |||
| EORTC | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| North America | 6 (50.0) | 7 (58.3) | 6 (50.0) |
| Age, y | |||
| N | 12 | 12 | 12 |
| Mean (SD) | 48.3 (10.28) | 48.3 (9.19) | 42.5 (12.97) |
| Median | 50.0 | 48.5 | 43.5 |
| Range | 29.0, 66.0 | 31.0, 64.0 | 18.0, 61.0 |
| Sex, n (%) | |||
| Female | 3 (25.0) | 6 (50.0) | 2 (16.7) |
| Male | 9 (75.0) | 6 (50.0) | 10 (83.3) |
| ECOG Performance Score, n (%) | |||
| 0 | 9 (75.0) | 8 (66.7) | 9 (75.0) |
| 1 | 3 (25.0) | 4 (33.3) | 3 (25.0) |
| Previous Cancer, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 0 (0.0) |
| No | 11 (91.7) | 12 (100.0) | 12 (100.0) |
| Site Primary Tumor, n (%) | |||
| Right | 6 (50.0) | 8 (66.7) | 9 (75.0) |
| Left | 5 (41.7) | 3 (25.0) | 3 (25.0) |
| Bilateral | 1 (8.3) | 1 (8.3) | 0 (0.0) |
| Corticosteroid Therapy at Entry, n (%) | |||
| Yes | 3 (25.0) | 1 (8.3) | 4 (33.3) |
| No | 9 (75.0) | 11 (91.7) | 8 (66.7) |
| Extent Surgical Resection, n (%) | |||
| Biopsy | 0 (0.0) | 1 (8.3) | 2 (16.7) |
| Subtotal resection | 6 (50.0) | 6 (50.0) | 4 (33.3) |
| Gross total resection | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| Prior History Brain Tumor, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 1 (8.3) |
| No | 11 (91.7) | 12 (100.0) | 11 (91.7) |
| . | Arm A: RT Alone (N = 12) . | Arm B: RT + Concomitant TMZ (N = 12) . | Arm C: TMZ Alone (N = 12) . |
|---|---|---|---|
| Group, n (%) | |||
| EORTC | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| North America | 6 (50.0) | 7 (58.3) | 6 (50.0) |
| Age, y | |||
| N | 12 | 12 | 12 |
| Mean (SD) | 48.3 (10.28) | 48.3 (9.19) | 42.5 (12.97) |
| Median | 50.0 | 48.5 | 43.5 |
| Range | 29.0, 66.0 | 31.0, 64.0 | 18.0, 61.0 |
| Sex, n (%) | |||
| Female | 3 (25.0) | 6 (50.0) | 2 (16.7) |
| Male | 9 (75.0) | 6 (50.0) | 10 (83.3) |
| ECOG Performance Score, n (%) | |||
| 0 | 9 (75.0) | 8 (66.7) | 9 (75.0) |
| 1 | 3 (25.0) | 4 (33.3) | 3 (25.0) |
| Previous Cancer, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 0 (0.0) |
| No | 11 (91.7) | 12 (100.0) | 12 (100.0) |
| Site Primary Tumor, n (%) | |||
| Right | 6 (50.0) | 8 (66.7) | 9 (75.0) |
| Left | 5 (41.7) | 3 (25.0) | 3 (25.0) |
| Bilateral | 1 (8.3) | 1 (8.3) | 0 (0.0) |
| Corticosteroid Therapy at Entry, n (%) | |||
| Yes | 3 (25.0) | 1 (8.3) | 4 (33.3) |
| No | 9 (75.0) | 11 (91.7) | 8 (66.7) |
| Extent Surgical Resection, n (%) | |||
| Biopsy | 0 (0.0) | 1 (8.3) | 2 (16.7) |
| Subtotal resection | 6 (50.0) | 6 (50.0) | 4 (33.3) |
| Gross total resection | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| Prior History Brain Tumor, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 1 (8.3) |
| No | 11 (91.7) | 12 (100.0) | 11 (91.7) |
| . | Arm A: RT Alone (N = 12) . | Arm B: RT + Concomitant TMZ (N = 12) . | Arm C: TMZ Alone (N = 12) . |
|---|---|---|---|
| Group, n (%) | |||
| EORTC | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| North America | 6 (50.0) | 7 (58.3) | 6 (50.0) |
| Age, y | |||
| N | 12 | 12 | 12 |
| Mean (SD) | 48.3 (10.28) | 48.3 (9.19) | 42.5 (12.97) |
| Median | 50.0 | 48.5 | 43.5 |
| Range | 29.0, 66.0 | 31.0, 64.0 | 18.0, 61.0 |
| Sex, n (%) | |||
| Female | 3 (25.0) | 6 (50.0) | 2 (16.7) |
| Male | 9 (75.0) | 6 (50.0) | 10 (83.3) |
| ECOG Performance Score, n (%) | |||
| 0 | 9 (75.0) | 8 (66.7) | 9 (75.0) |
| 1 | 3 (25.0) | 4 (33.3) | 3 (25.0) |
| Previous Cancer, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 0 (0.0) |
| No | 11 (91.7) | 12 (100.0) | 12 (100.0) |
| Site Primary Tumor, n (%) | |||
| Right | 6 (50.0) | 8 (66.7) | 9 (75.0) |
| Left | 5 (41.7) | 3 (25.0) | 3 (25.0) |
| Bilateral | 1 (8.3) | 1 (8.3) | 0 (0.0) |
| Corticosteroid Therapy at Entry, n (%) | |||
| Yes | 3 (25.0) | 1 (8.3) | 4 (33.3) |
| No | 9 (75.0) | 11 (91.7) | 8 (66.7) |
| Extent Surgical Resection, n (%) | |||
| Biopsy | 0 (0.0) | 1 (8.3) | 2 (16.7) |
| Subtotal resection | 6 (50.0) | 6 (50.0) | 4 (33.3) |
| Gross total resection | 6 (50.0) | 5 (41.7) | 6 (50.0) |
| Prior History Brain Tumor, n (%) | |||
| Yes | 1 (8.3) | 0 (0.0) | 1 (8.3) |
| No | 11 (91.7) | 12 (100.0) | 11 (91.7) |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
